Table 2

Hierarchical Logistic Regression Analysis of Receipt of ART, Cancer Screening, and Health Care Use

Variable	Receipt of ART AOR (95% CI)^a	Colorectal Cancer Screening AOR (95% CI)^a	Cervical Cancer Screening AOR (95% CI)^a	Breast Cancer Screening AOR (95% CI)^a	Any ED Visit AOR (95% CI)^a	Any Hospital Admission
Model of care delivery
FP-dominant comanagement	2.04 (1.63–2.25)	1.25 (0.88–1.76)	0.77 (0.47–1.27)	3.90 (1.16–13.09)	1.11 (0.96–1.29)	2.16 (1.75–2.67)
Specialist-dominant comanagement	2.23 (1.71–2.91)	0.88 (0.59–1.31)	0.72 (0.44–1.18	0.49 (0.13–1.79)	1.11 (0.94–1.31)	1.57 (1.22–2.02)
Exclusively primary care (ref)	1.00^b	1.00^b	1.00	1.00	1.00	1.00^b
Family physician HIV experience^b
≤5 HIV patients	0.16 (0.12–0.21)	0.85 (0.56–1.29)	1.09 (0.70–1.69)	2.10 (0.84–5.27)	1.16 (0.98–1.37)	1.17 (0.89–1.53)
6–49 HIV patients	0.20 (0.15–0.27)	0.67 (0.42–1.08)	0.59 (0.35–0.99)	1.69 (0.58–4.91)	1.12 (0.92–1.37)	1.40 (1.02–1.91)
≥50 HIV patients (ref)	1.00	1.00	1.00	1.00	1.00	1.00
Interaction model^c FP HIV experience
FP-dominant comanagement^c ≤5 HIV patients	6.27 (2.40–16.34)^b	0.98 (0.26–3.63)	1.45 (0.34–6.15)	0.08 (0.01–1.05)	0.65 (0.33–1.29)	1.24 (0.58–2.66)
FP-dominant comanagement^c 6–49 HIV patients	6.33 (2.92–13.71)^b	1.17 (0.44–3.07)	0.67 (0.18–2.51)	0.09 (0.01–1.08)	0.85 (0.53–1.36)	0.70 (0.38–1.30)
SP-dominant comanagement^c ≤5 HIV patients	5.92 (4.10–8.57)^b	0.76 (0.44–1.30)	0.96 (0.54–1.71)	0.87 (0.21–3.67)	0.90 (0.72–1.14)	0.87 (0.61–1.24)
SP dominant comanagement^c 6–49 HIV patients	4.54 (3.01–6.86)^b	0.73 (0.39–1.38)	1.30 (0.67–2.53)	2.06 (0.41–10.36)	1.01 (0.77–1.32)	0.65 (0.43–0.98)
Age, years	1.01 (1.00–1.01)	1.02 (1.00–1.04)^b	0.98 (0.97–0.99)^b	1.07 (1.01–1.12)^b	0.99 (0.98–0.99)^b	1.02 (1.02–1.03)^b
Sex, female	0.88 (0.74–1.04)	1.05 (0.79–1.39)	–	–	1.07 (0.95–1.20)	0.97 (0.82–1.16)
Neighborhood income quintile
Quintile 1 (lowest)	1.42 (1.12–1.73)	0.95 (0.71–1.27)	0.95 (0.66–1.36)	0.45 (0.20–1.00)	1.15 (1.01–1.30)	1.12 (0.92–1.36)
Quintile 2	1.05 (0.85–1.28)	0.88 (0.64–1.21)	0.98 (0.66–1.44)	0.32 (0.14–0.76)	1.00 (0.87–1.15)	1.02 (0.83–1.27)
Quintile 3	0.96 (0.81–1.25)	1.15 (0.83–1.59)	1.18 (0.78–1.77)	0.79 (0.33–1.90)	0.95 (0.82–1.10)	0.96 (0.77–1.20)
Quintile 4	1.09 (0.88–1.34)	0.86 (0.62–1.21)	1.09 (0.71–1.66)	0.68 (0.27–1.76)	0.90 (0.77–1.04)	0.88 (0.69–1.11)
Quintile 5 (highest) (ref)	1.00^b	1.00	1.00	1.00^d	1.00^b	1.00
Rurality index^d
Non–major urban	1.35 (1.04–1.69)	0.95 (0.68–1.32)	0.91 (0.61–1.35)	0.54 (0.25–1.15)	1.49 (1.28–1.73)	1.41 (1.13–1.75)
Rural	1.18 (0.75–1.88)	0.66 (0.34–1.30)	0.70 (0.31–1.58)	0.38 (0.10–1.54)	1.79 (1.31–2.44)	1.82 (1.22–2.70)
Urban (ref)	1.00	1.00	1.00	1.00	1.00^b	1.00^b
Immigrant status^b
Immigrant from Africa or Caribbean	1.58 (1.24–1.99)	0.90 (0.60–1.34)	1.04 (0.81–1.33)	1.66 (0.90–3.09)	0.77 (0.67–0.90)^b	0.80 (0.63–1.02)^b
Immigrant from Europe or western nations	0.78 (0.50–1.24)	1.69 (0.78–3.64)	0.57 (0.23–1.38)	0.40 (0.06–2.82)	0.61 (0.44–0.85)	0.67 (0.38–1.20)
Immigrant from other country	1.29 (1.00–1.68)	0.97 (0.60–1.57)	0.69 (0.46–1.03)	0.68 (0.28–1.69)	0.71 (0.59–0.84)	0.66 (0.49–0.90)
Canadian born (ref)	1.00^b	1.00	1.00	1.00	1.00	1.00
Mental health diagnosis	0.81 (0.71–0.93)^b	0.71 (0.58–0.87)^b	0.93 (0.75–1.15)	1.23 (0.77–1.99)	1.37 (1.26–1.50)^b	1.28 (1.12–1.46)^b
Comorbidity: ADG category
High	0.69 (0.59–0.82)	1.55 (1.19–2.03)	1.33 (1.01–1.73)	1.84 (0.97–2.48)	3.31 (2.95–3.71)^b	3.45 (2.90–4.11)
Medium	0.88 (0.75–1.02)	1.54 (1.23–1.92)	1.62 (1.27–2.08)	2.31 (1.27–4.21)	1.59 (1.43–1.76)	1.60 (1.35–1.91)
Low (ref)	1.00^b	1.00^b	1.00^b	1.00^b	1.00	1.00^b

ADG = aggregated diagnosis group; AOR = adjusted odds ratio; ART = antiretroviral therapy; ED = emergency department; FP = family physician; ref = reference group.
↵a Adjusted for all listed patient covariates and interaction term of model of care delivery.
↵b Statistically significant (P for overall test of effect <.05).
↵c Family physician experience.
↵d P = .06.
Note: Analyses account for family physician cluster.